Health Care/Hospital

I-Mab Added to Nasdaq Biotechnology Index

SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...

2020-12-14 21:00 9253

Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration

HONG KONG, Dec. 14, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Orient EuroPharma Co., L...

2020-12-14 20:20 4306

Canadian pilot study suggests prescription icosapent ethyl (VASCEPA®) might improve symptoms of COVID-19 and reduce inflammation

TORONTO, ON, Dec. 14, 2020 /PRNewswire/ -- The results of a Canadian study released this weekend provides encouraging data suggesting that the prescription strength omega-3 called icosapent ethyl (VASCEPA) may reduce inflammation and improve symptoms in patients with a diagnosis of COVID-19. "Th...

2020-12-14 20:00 2700

Sai Life Sciences releases its first Sustainability Report

- Developed as per the Global Reporting Initiative (GRI) standards - Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path HYDERABAD, India, Dec. 14, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Resear...

2020-12-14 18:42 2913

Hummingbird Bioscience Announces Collaboration with Tempus to Harness AI-driven Precision Medicine to Accelerate Clinical Development of HMBD-001 In HER3 Driven Cancers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, today announced a collaboration with Tempus, a leader in artificial intelligence and precision medicine, to drive t...

2020-12-14 18:00 1901

Ortoma launches OTS 5 according to plan

STOCKHOLM, Dec. 14, 2020 /PRNewswire/ -- Ortoma, manufacturer of surgical assistive technology for planning and positioning of implants, launches the latest version of the company's surgical system Ortoma Treatment Solution (OTS), which is based on AI (Artificial Intelligence). Ongoing active mar...

2020-12-14 16:28 1495

Exploring Breast Cancer from a 3-Dimensional Perspective

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Every October, the streets (and Internet) are rife with various awareness campaigns and pink ribbon projects that boost information on breast cancer and available screening methods. Despite an abundance of information available through mass-distributed br...

2020-12-14 15:31 1652

China Life Singapore-special supported 'Love & Hope' Gala Concert to be dedicated to outstanding frontline workers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- On December 13, 2020, the "Love & Hope" Gala Concert, organized by Huaxia Cultural Hub, was held in the Singapore Conference Hall, presenting a wonderful musical performance for locals. China Life Insurance (Singapore) Pte. Ltd. ("China Life Singapore")pro...

2020-12-14 14:44 3211

TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors

BANGKOK, Dec. 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in collaboration with Department of Disease Control, has launched the specialised training for Destination Management Company (DMC) to design health-compliant itineraries as part of a government's special ar...

2020-12-14 14:29 2326

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances

PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Plat...

2020-12-14 13:00 1499

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted onDecember 8, 2020. The management team conducted an online dialogue with nearly 400 investors, focusing on the company's strategy, personnel plans, technology platforms, integration strategic plans...

2020-12-14 12:15 2776

Global HealthTech Market will grow to US$ 456.85 Mn by 2028 at 19% CAGR- says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ -- * The global healthtech market was valued atUS$ 96.11 Bn in 2019. The adoption of single use technology has experienced a rise in the healthcare industry durin...

2020-12-14 11:00 3288

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan

SOMERSET, N.J., Dec. 14, 2020 /PRNewswire/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya "N...

2020-12-14 10:28 5171

Senhwa Biosciences's Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium

TAIPEI and SAN DIEGO, Dec. 13, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer , announced their Abstract on Cholangiocarcinoma treatment with Silmit...

2020-12-14 10:09 1986

High prevalence of hospital malnutrition associated with poor clinical outcomes

BAD HOMBURG, Germany, Dec. 14, 2020 /PRNewswire/ -- Hospital malnutrition is documented in many observational studies fromthe United States, Europe, and Latin America. A recently published literature review found that malnutrition is highly prevalent across different hospital patient groups in...

2020-12-14 10:00 2183

Global Respiratory Clinics Market will grow at a CAGR of 20.7% over the forecast period - says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ --   Respiratory Clinics Market will grow at a CAGR of 20.7% * In the United States currently more than 25 million people are diagnosed with asthma, because of thes...

2020-12-14 10:00 2692

NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...

2020-12-14 09:00 1472

NCH Asia Pacific calls for consistent maintenance and vigilance during this pandemic with the 'NCH Disinfection Program'

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- NCH Asia Pacific is a global leader in industrial and commercial maintenance products and services since 1919. The company was formed during the 1918 pandemic and harkens back to the time when we all beat the flu using disinfectants and by observing prop...

2020-12-14 09:00 2524

Global Respiratory Care Devices Market was Valued at US$ 15527.49 Mn in 2019 Growing at a CAGR of 12.25% over the Forecast Period- says Absolute Markets Insights

PUNE, India, Dec. 14, 2020 /PRNewswire/ -- * The COVID-19 pandemic is expected to have a positive impact on the global respiratory care devices market in the coming years. This is because of the increasin...

2020-12-14 09:00 2615

The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention

GENEVA and CASTRES , France, Dec. 14, 2020 /PRNewswire/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked...

2020-12-14 09:00 2191